Local 12: UC researchers study how to personalize COVID-19 treatments

The University of Cincinnati's Bingfang Yan, PhD, DVM, has received a $2.5 million National Institutes of Health grant to study how currently approved COVID-19 therapeutics can work together to create more effective and safe treatments for patients.

“The question we are asking is, can we combine two of those, or even three of those, that can produce better favor or more effective treatment?" Yan, professor and associate dean for research and innovation at UC's James L. Winkle College of Pharmacy, told Local 12 News.

Yan said finding out more about how these drugs can be given in combination will not only help treat COVID, but may be useful in treating other viruses like influenza.

Watch the Local 12 story.

Yan also spoke about the research on 55KRC's Simply Medicine radio show and podcast. Listen to the Simply Medicine interview. (Note: Segment begins around 17:55 mark of episode.)

Read more about the research.

Featured photo at top of remdesivir in an IV bag. Photo/Dimitri Karastelev/Unsplash.

Related Stories